As of June 21, 2025, Brainsway Ltd (BWAY.TA) reports a ROE (Return on Equity) of 4.69%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Brainsway Ltd's ROE (Return on Equity)
Over recent years, Brainsway Ltd's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 4.69% |
| 2023-12-31 | -10.09% |
| 2022-12-31 | -29.41% |
| 2021-12-31 | -11.27% |
| 2020-12-31 | -27.46% |
This slight upward trend highlights how Brainsway Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Brainsway Ltd's ROE (Return on Equity) to Peers
To better understand Brainsway Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Brainsway Ltd (BWAY.TA) | 4.69% |
| Elbit Medical Technologies Ltd (EMTC.TA) | 267.15% |
| Elbit Imaging Ltd (EMITF.TA) | 81.20% |
| L&K Biomed Co Ltd (156100.KQ) | 22.93% |
| Mediterranean Towers Ltd (MDTR.TA) | 17.96% |
| Boditech Med Inc (206640.KQ) | 12.96% |
Compared to its competitors, Brainsway Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.